An affordable decades-old drug has been reformulated and repurposed to treat COVID-19 patients. Following FDA and Health Canada’s approval, the drug has now begun phase three of a North American clinical trial. As Global’s Victoria Bakos reports, patient recruitment is launching in two weeks in Quebec and Ontario.
Canada
Affordable, decades-old drug PULM-001 proves promising in the fight against COVID-19
More Videos
-
Will signing a new charter to protect the Lake of Two Mountains help?
-
More elderly Montrealers living on the streets, say advocates
-
Pierrefonds mayor and residents on edge after new flood maps show more homes at risk
-
Port of Montreal longshore workers start 3-day strike
-
Lachine community remembers teen cyclist killed by truck more than 10 years ago
-
Greater Montreal public transit agencies running $500M deficit
You are viewing an Accelerated Mobile Webpage.
View Original Article